Yuyu Pharma Statistics
Total Valuation
Yuyu Pharma has a market cap or net worth of KRW 75.49 billion. The enterprise value is 78.91 billion.
Market Cap | 75.49B |
Enterprise Value | 78.91B |
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025.
Earnings Date | May 13, 2025 |
Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
Yuyu Pharma has 16.18 million shares outstanding. The number of shares has increased by 3.29% in one year.
Current Share Class | n/a |
Shares Outstanding | 16.18M |
Shares Change (YoY) | +3.29% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 34.99% |
Owned by Institutions (%) | 0.09% |
Float | 10.52M |
Valuation Ratios
The trailing PE ratio is 10.08.
PE Ratio | 10.08 |
Forward PE | n/a |
PS Ratio | 0.57 |
PB Ratio | 0.56 |
P/TBV Ratio | 0.63 |
P/FCF Ratio | 4.23 |
P/OCF Ratio | 3.03 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.31, with an EV/FCF ratio of 4.42.
EV / Earnings | 10.42 |
EV / Sales | 0.59 |
EV / EBITDA | 4.31 |
EV / EBIT | 6.24 |
EV / FCF | 4.42 |
Financial Position
The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.25.
Current Ratio | 1.58 |
Quick Ratio | 0.97 |
Debt / Equity | 0.25 |
Debt / EBITDA | 1.84 |
Debt / FCF | 1.89 |
Interest Coverage | 3.91 |
Financial Efficiency
Return on equity (ROE) is 8.06% and return on invested capital (ROIC) is 4.79%.
Return on Equity (ROE) | 8.06% |
Return on Assets (ROA) | 3.87% |
Return on Invested Capital (ROIC) | 4.79% |
Return on Capital Employed (ROCE) | 8.79% |
Revenue Per Employee | 526.27M |
Profits Per Employee | 29.94M |
Employee Count | 253 |
Asset Turnover | 0.66 |
Inventory Turnover | 1.98 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.31% in the last 52 weeks. The beta is 0.55, so Yuyu Pharma's price volatility has been lower than the market average.
Beta (5Y) | 0.55 |
52-Week Price Change | +2.31% |
50-Day Moving Average | 4,504.20 |
200-Day Moving Average | 4,601.23 |
Relative Strength Index (RSI) | 64.04 |
Average Volume (20 Days) | 77,612 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Yuyu Pharma had revenue of KRW 133.15 billion and earned 7.58 billion in profits. Earnings per share was 462.90.
Revenue | 133.15B |
Gross Profit | 51.37B |
Operating Income | 12.58B |
Pretax Income | 9.98B |
Net Income | 7.58B |
EBITDA | 18.25B |
EBIT | 12.58B |
Earnings Per Share (EPS) | 462.90 |
Balance Sheet
The company has 42.65 billion in cash and 33.64 billion in debt, giving a net cash position of 9.01 billion or 556.48 per share.
Cash & Cash Equivalents | 42.65B |
Total Debt | 33.64B |
Net Cash | 9.01B |
Net Cash Per Share | 556.48 |
Equity (Book Value) | 135.06B |
Book Value Per Share | 7,578.44 |
Working Capital | 37.47B |
Cash Flow
In the last 12 months, operating cash flow was 24.95 billion and capital expenditures -7.11 billion, giving a free cash flow of 17.84 billion.
Operating Cash Flow | 24.95B |
Capital Expenditures | -7.11B |
Free Cash Flow | 17.84B |
FCF Per Share | 1,102.29 |
Margins
Gross margin is 38.58%, with operating and profit margins of 9.45% and 6.55%.
Gross Margin | 38.58% |
Operating Margin | 9.45% |
Pretax Margin | 7.50% |
Profit Margin | 6.55% |
EBITDA Margin | 13.71% |
EBIT Margin | 9.45% |
FCF Margin | 13.40% |
Dividends & Yields
This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 2.15%.
Dividend Per Share | 100.00 |
Dividend Yield | 2.15% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.29% |
Shareholder Yield | -1.14% |
Earnings Yield | 10.03% |
FCF Yield | 23.63% |
Stock Splits
The last stock split was on March 30, 2021. It was a forward split with a ratio of 2.
Last Split Date | Mar 30, 2021 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Yuyu Pharma has an Altman Z-Score of 1.87. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.87 |
Piotroski F-Score | n/a |